• Explore /
  • Poster
  • / A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular carcinoma (HCC) and other gastrointestinal (GI) malignancies.

A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular carcinoma (HCC) and other gastrointestinal (GI) malignancies.

Abstract Poster

Authors

null

James J. Harding

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY

James J. Harding , Maeve Aine Lowery , Khrystyna Uhlitskykh , Peter Justin Wan , Casey R Hamilton , Adalberto Barba , Kay Chia-Wei Liu , Amanda Johnston , John S. Bomalaski , Eileen Mary O'Reilly , Leonard Saltz , Ghassan K. Abou-Alfa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02102022

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 384)

DOI

10.1200/JCO.2017.35.4_suppl.384

Abstract #

384

Poster Bd #

H10

Abstract Disclosures

Similar Posters

First Author: Kazufumi Kobayashi

First Author: Patricio Eduardo Yanez

First Author: Masatoshi Kudo

Poster

2019 Gastrointestinal Cancers Symposium

Phase I results from the phase 1/3 FIGHT study evaluating bemarituzumab and mFOLFOX6 in advanced gastric/GEJ cancer (GC).

Phase I results from the phase 1/3 FIGHT study evaluating bemarituzumab and mFOLFOX6 in advanced gastric/GEJ cancer (GC).

First Author: Mohamedtaki Abdulaziz Tejani